Wordt geladen...
Bilirubin, a new therapeutic for kidney transplant?
In patients with end-stage renal disease, kidney transplantation has been associated with numerous benefits, including increased daily activity, and better survival rates. However, over 20% of kidney transplants result in rejection within five years. Rejection is primarily due to a hypersensitive im...
Bewaard in:
| Gepubliceerd in: | Transplant Rev (Orlando) |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535229/ https://ncbi.nlm.nih.gov/pubmed/29983261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trre.2018.06.003 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|